Advanced in Bronchiectasis

Rajesh N. Swarnakar

Nagpur, MH, IN 
Advanced in Bronchiectasis
Nagpur, MH, IN 
OverviewLocationsClinical Research

Overview

Rajesh Swarnakar practices in Nagpur, India. Mr. Swarnakar is rated as an Advanced expert by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Bronchiectasis, Allergic Bronchopulmonary Aspergillosis, Bronchitis, Hypersensitivity Pneumonitis, and Endoscopy.

His clinical research consists of co-authoring 29 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Bronchiectasis.

Gender
Male

Locations

Nagpur, MH, India
Other Locations
Dhantoli, MH, India
New Delhi, DL, India
Chandigarh, CH, India
Hingana, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 4, Open-label, Single Arm, 24-week, Study to Evaluate the Safety and Efficacy of Mepolizumab 100 mg SC Administered Every 4 Weeks in Indian Participants Aged ≥18 Years With Severe Eosinophilic asthMa (PRISM)
A Phase 4, Open-label, Single Arm, 24-week, Study to Evaluate the Safety and Efficacy of Mepolizumab 100 mg SC Administered Every 4 Weeks in Indian Participants Aged ≥18 Years With Severe Eosinophilic asthMa (PRISM)
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Drug
Study Phase: Phase 4

29 Total Publications

Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM).
Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM).
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Swarnakar's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile